Breaking News, Promotions & Moves

Incyte Appointments Dave Gardner, EVP & Chief Strategy Officer

Gardner joins with over 20 years of experience in pharmaceutical and biotechnology investing and advising.

By: Rachel Klemovitch

Assistant Editor

Incyte named Dave Gardner Executive Vice President and Chief Strategy Officer (CSO) effective September 22, 2025. In his new role, Gardner will serve as a key member of the Executive Leadership Team and be responsible for the company’s strategy and business development. After nine years as a key member of the Incyte leadership team, Vijay Iyengar, M.D., Executive Vice President and Head of Global Medical Affairs and Product and Partnership Strategy, will be retiring from Incyte and will conti...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters